 | • レポートコード：MRC2-11QY04046 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はオリゴヌクレオチド合成のグローバル市場について調査・分析したレポートです。種類別（合成オリゴヌクレオチド、試薬、機器）市場規模、用途別（PCR、DNA、RNAi、研究、治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オリゴヌクレオチド合成の競争状況、市場シェア ・世界のオリゴヌクレオチド合成市場：種類別市場規模 2015年-2020年（合成オリゴヌクレオチド、試薬、機器） ・世界のオリゴヌクレオチド合成市場：種類別市場規模予測 2021年-2026年（合成オリゴヌクレオチド、試薬、機器） ・世界のオリゴヌクレオチド合成市場：用途別市場規模 2015年-2020年（PCR、DNA、RNAi、研究、治療） ・世界のオリゴヌクレオチド合成市場：用途別市場規模予測 2021年-2026年（PCR、DNA、RNAi、研究、治療） ・北米のオリゴヌクレオチド合成市場分析：米国、カナダ ・ヨーロッパのオリゴヌクレオチド合成市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオリゴヌクレオチド合成市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオリゴヌクレオチド合成市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオリゴヌクレオチド合成市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Integrated DNA Technologies、Merck KGaA、Eurofins Genomics、Thermo Fisher Scientific、Bioautomation、Agilent Technologies、Eurogentec、GE Healthcare、LGC Biosearch Technologies、Nitto Denko Avecia、Genscript、Genedesign、TriLink Biotechnologies、Bio-Synthesis、ATDBio ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.
Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.
Market Analysis and Insights: Global Oligonucleotide Synthesis Market
The global Oligonucleotide Synthesis market size is projected to reach US$ 1913.7 million by 2026, from US$ 1790.7 million in 2020, at a CAGR of 6.4%% during 2021-2026.
Global Oligonucleotide Synthesis Scope and Market Size
Oligonucleotide Synthesis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotide Synthesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Integrated DNA Technologies
Merck KGaA
Eurofins Genomics
Thermo Fisher Scientific
Bioautomation
Agilent Technologies
Eurogentec
GE Healthcare
LGC Biosearch Technologies
Nitto Denko Avecia
Genscript
Genedesign
TriLink Biotechnologies
Bio-Synthesis
ATDBio
Market segment by Type, the product can be split into
Synthesized Oligonucleotides
Reagents
Equipment
Market segment by Application, split into
PCR
DNA
RNAi
Research
Therapeutic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oligonucleotide Synthesis Revenue
1.4 Market by Type
1.4.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Synthesized Oligonucleotides
1.4.3 Reagents
1.4.4 Equipment
1.5 Market by Application
1.5.1 Global Oligonucleotide Synthesis Market Share by Application: 2020 VS 2026
1.5.2 PCR
1.5.3 DNA
1.5.4 RNAi
1.5.5 Research
1.5.6 Therapeutic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Synthesis Market Perspective (2015-2026)
2.2 Global Oligonucleotide Synthesis Growth Trends by Regions
2.2.1 Oligonucleotide Synthesis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oligonucleotide Synthesis Historic Market Share by Regions (2015-2020)
2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oligonucleotide Synthesis Market Growth Strategy
2.3.6 Primary Interviews with Key Oligonucleotide Synthesis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Synthesis Players by Market Size
3.1.1 Global Top Oligonucleotide Synthesis Players by Revenue (2015-2020)
3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2015-2020)
3.1.3 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oligonucleotide Synthesis Market Concentration Ratio
3.2.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2019
3.3 Oligonucleotide Synthesis Key Players Head office and Area Served
3.4 Key Players Oligonucleotide Synthesis Product Solution and Service
3.5 Date of Enter into Oligonucleotide Synthesis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2015-2020)
4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Oligonucleotide Synthesis Market Size by Application (2015-2020)
5.2 Global Oligonucleotide Synthesis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oligonucleotide Synthesis Market Size (2015-2020)
6.2 Oligonucleotide Synthesis Key Players in North America (2019-2020)
6.3 North America Oligonucleotide Synthesis Market Size by Type (2015-2020)
6.4 North America Oligonucleotide Synthesis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oligonucleotide Synthesis Market Size (2015-2020)
7.2 Oligonucleotide Synthesis Key Players in Europe (2019-2020)
7.3 Europe Oligonucleotide Synthesis Market Size by Type (2015-2020)
7.4 Europe Oligonucleotide Synthesis Market Size by Application (2015-2020)
8 China
8.1 China Oligonucleotide Synthesis Market Size (2015-2020)
8.2 Oligonucleotide Synthesis Key Players in China (2019-2020)
8.3 China Oligonucleotide Synthesis Market Size by Type (2015-2020)
8.4 China Oligonucleotide Synthesis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Oligonucleotide Synthesis Market Size (2015-2020)
9.2 Oligonucleotide Synthesis Key Players in Japan (2019-2020)
9.3 Japan Oligonucleotide Synthesis Market Size by Type (2015-2020)
9.4 Japan Oligonucleotide Synthesis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Oligonucleotide Synthesis Market Size (2015-2020)
10.2 Oligonucleotide Synthesis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oligonucleotide Synthesis Market Size by Type (2015-2020)
10.4 Southeast Asia Oligonucleotide Synthesis Market Size by Application (2015-2020)
11 India
11.1 India Oligonucleotide Synthesis Market Size (2015-2020)
11.2 Oligonucleotide Synthesis Key Players in India (2019-2020)
11.3 India Oligonucleotide Synthesis Market Size by Type (2015-2020)
11.4 India Oligonucleotide Synthesis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Oligonucleotide Synthesis Market Size (2015-2020)
12.2 Oligonucleotide Synthesis Key Players in Central & South America (2019-2020)
12.3 Central & South America Oligonucleotide Synthesis Market Size by Type (2015-2020)
12.4 Central & South America Oligonucleotide Synthesis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Integrated DNA Technologies
13.1.1 Integrated DNA Technologies Company Details
13.1.2 Integrated DNA Technologies Business Overview
13.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction
13.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020))
13.1.5 Integrated DNA Technologies Recent Development
13.2 Merck KGaA
13.2.1 Merck KGaA Company Details
13.2.2 Merck KGaA Business Overview
13.2.3 Merck KGaA Oligonucleotide Synthesis Introduction
13.2.4 Merck KGaA Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.2.5 Merck KGaA Recent Development
13.3 Eurofins Genomics
13.3.1 Eurofins Genomics Company Details
13.3.2 Eurofins Genomics Business Overview
13.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction
13.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.3.5 Eurofins Genomics Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview
13.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction
13.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Bioautomation
13.5.1 Bioautomation Company Details
13.5.2 Bioautomation Business Overview
13.5.3 Bioautomation Oligonucleotide Synthesis Introduction
13.5.4 Bioautomation Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.5.5 Bioautomation Recent Development
13.6 Agilent Technologies
13.6.1 Agilent Technologies Company Details
13.6.2 Agilent Technologies Business Overview
13.6.3 Agilent Technologies Oligonucleotide Synthesis Introduction
13.6.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.6.5 Agilent Technologies Recent Development
13.7 Eurogentec
13.7.1 Eurogentec Company Details
13.7.2 Eurogentec Business Overview
13.7.3 Eurogentec Oligonucleotide Synthesis Introduction
13.7.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.7.5 Eurogentec Recent Development
13.8 GE Healthcare
13.8.1 GE Healthcare Company Details
13.8.2 GE Healthcare Business Overview
13.8.3 GE Healthcare Oligonucleotide Synthesis Introduction
13.8.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.8.5 GE Healthcare Recent Development
13.9 LGC Biosearch Technologies
13.9.1 LGC Biosearch Technologies Company Details
13.9.2 LGC Biosearch Technologies Business Overview
13.9.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction
13.9.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.9.5 LGC Biosearch Technologies Recent Development
13.10 Nitto Denko Avecia
13.10.1 Nitto Denko Avecia Company Details
13.10.2 Nitto Denko Avecia Business Overview
13.10.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction
13.10.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2015-2020)
13.10.5 Nitto Denko Avecia Recent Development
13.11 Genscript
10.11.1 Genscript Company Details
10.11.2 Genscript Business Overview
10.11.3 Genscript Oligonucleotide Synthesis Introduction
10.11.4 Genscript Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.11.5 Genscript Recent Development
13.12 Genedesign
10.12.1 Genedesign Company Details
10.12.2 Genedesign Business Overview
10.12.3 Genedesign Oligonucleotide Synthesis Introduction
10.12.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.12.5 Genedesign Recent Development
13.13 TriLink Biotechnologies
10.13.1 TriLink Biotechnologies Company Details
10.13.2 TriLink Biotechnologies Business Overview
10.13.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction
10.13.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.13.5 TriLink Biotechnologies Recent Development
13.14 Bio-Synthesis
10.14.1 Bio-Synthesis Company Details
10.14.2 Bio-Synthesis Business Overview
10.14.3 Bio-Synthesis Oligonucleotide Synthesis Introduction
10.14.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.14.5 Bio-Synthesis Recent Development
13.15 ATDBio
10.15.1 ATDBio Company Details
10.15.2 ATDBio Business Overview
10.15.3 ATDBio Oligonucleotide Synthesis Introduction
10.15.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2015-2020)
10.15.5 ATDBio Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Oligonucleotide Synthesis Key Market Segments
Table 2. Key Players Covered: Ranking by Oligonucleotide Synthesis Revenue
Table 3. Ranking of Global Top Oligonucleotide Synthesis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Synthesized Oligonucleotides
Table 6. Key Players of Reagents
Table 7. Key Players of Equipment
Table 8. Global Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Oligonucleotide Synthesis Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Oligonucleotide Synthesis Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Oligonucleotide Synthesis Market Share by Regions (2015-2020)
Table 12. Global Oligonucleotide Synthesis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Oligonucleotide Synthesis Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Oligonucleotide Synthesis Market Growth Strategy
Table 18. Main Points Interviewed from Key Oligonucleotide Synthesis Players
Table 19. Global Oligonucleotide Synthesis Revenue by Players (2015-2020) (Million US$)
Table 20. Global Oligonucleotide Synthesis Market Share by Players (2015-2020)
Table 21. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2019)
Table 22. Global Oligonucleotide Synthesis by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Oligonucleotide Synthesis Product Solution and Service
Table 25. Date of Enter into Oligonucleotide Synthesis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 28. Global Oligonucleotide Synthesis Market Size Share by Type (2015-2020)
Table 29. Global Oligonucleotide Synthesis Revenue Market Share by Type (2021-2026)
Table 30. Global Oligonucleotide Synthesis Market Size Share by Application (2015-2020)
Table 31. Global Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 32. Global Oligonucleotide Synthesis Market Size Share by Application (2021-2026)
Table 33. North America Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 35. North America Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 36. North America Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 37. North America Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 38. North America Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 39. Europe Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 41. Europe Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 43. Europe Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 45. China Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 46. China Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 47. China Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 48. China Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 49. China Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 50. China Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 51. Japan Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 53. Japan Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 55. Japan Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 59. Southeast Asia Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 61. Southeast Asia Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 63. India Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 64. India Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 65. India Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 66. India Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 67. India Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 68. India Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Oligonucleotide Synthesis Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Oligonucleotide Synthesis Market Share (2019-2020)
Table 71. Central & South America Oligonucleotide Synthesis Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Oligonucleotide Synthesis Market Share by Type (2015-2020)
Table 73. Central & South America Oligonucleotide Synthesis Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Oligonucleotide Synthesis Market Share by Application (2015-2020)
Table 75. Integrated DNA Technologies Company Details
Table 76. Integrated DNA Technologies Business Overview
Table 77. Integrated DNA Technologies Product
Table 78. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 79. Integrated DNA Technologies Recent Development
Table 80. Merck KGaA Company Details
Table 81. Merck KGaA Business Overview
Table 82. Merck KGaA Product
Table 83. Merck KGaA Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 84. Merck KGaA Recent Development
Table 85. Eurofins Genomics Company Details
Table 86. Eurofins Genomics Business Overview
Table 87. Eurofins Genomics Product
Table 88. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 89. Eurofins Genomics Recent Development
Table 90. Thermo Fisher Scientific Company Details
Table 91. Thermo Fisher Scientific Business Overview
Table 92. Thermo Fisher Scientific Product
Table 93. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 94. Thermo Fisher Scientific Recent Development
Table 95. Bioautomation Company Details
Table 96. Bioautomation Business Overview
Table 97. Bioautomation Product
Table 98. Bioautomation Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 99. Bioautomation Recent Development
Table 100. Agilent Technologies Company Details
Table 101. Agilent Technologies Business Overview
Table 102. Agilent Technologies Product
Table 103. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 104. Agilent Technologies Recent Development
Table 105. Eurogentec Company Details
Table 106. Eurogentec Business Overview
Table 107. Eurogentec Product
Table 108. Eurogentec Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 109. Eurogentec Recent Development
Table 110. GE Healthcare Business Overview
Table 111. GE Healthcare Product
Table 112. GE Healthcare Company Details
Table 113. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 114. GE Healthcare Recent Development
Table 115. LGC Biosearch Technologies Company Details
Table 116. LGC Biosearch Technologies Business Overview
Table 117. LGC Biosearch Technologies Product
Table 118. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 119. LGC Biosearch Technologies Recent Development
Table 120. Nitto Denko Avecia Company Details
Table 121. Nitto Denko Avecia Business Overview
Table 122. Nitto Denko Avecia Product
Table 123. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 124. Nitto Denko Avecia Recent Development
Table 125. Genscript Company Details
Table 126. Genscript Business Overview
Table 127. Genscript Product
Table 128. Genscript Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 129. Genscript Recent Development
Table 130. Genedesign Company Details
Table 131. Genedesign Business Overview
Table 132. Genedesign Product
Table 133. Genedesign Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 134. Genedesign Recent Development
Table 135. TriLink Biotechnologies Company Details
Table 136. TriLink Biotechnologies Business Overview
Table 137. TriLink Biotechnologies Product
Table 138. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 139. TriLink Biotechnologies Recent Development
Table 140. Bio-Synthesis Company Details
Table 141. Bio-Synthesis Business Overview
Table 142. Bio-Synthesis Product
Table 143. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 144. Bio-Synthesis Recent Development
Table 145. ATDBio Company Details
Table 146. ATDBio Business Overview
Table 147. ATDBio Product
Table 148. ATDBio Revenue in Oligonucleotide Synthesis Business (2015-2020) (Million US$)
Table 149. ATDBio Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oligonucleotide Synthesis Market Share by Type: 2020 VS 2026
Figure 2. Synthesized Oligonucleotides Features
Figure 3. Reagents Features
Figure 4. Equipment Features
Figure 5. Global Oligonucleotide Synthesis Market Share by Application: 2020 VS 2026
Figure 6. PCR Case Studies
Figure 7. DNA Case Studies
Figure 8. RNAi Case Studies
Figure 9. Research Case Studies
Figure 10. Therapeutic Case Studies
Figure 11. Oligonucleotide Synthesis Report Years Considered
Figure 12. Global Oligonucleotide Synthesis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Oligonucleotide Synthesis Market Share by Regions: 2020 VS 2026
Figure 14. Global Oligonucleotide Synthesis Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Oligonucleotide Synthesis Market Share by Players in 2019
Figure 17. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2019
Figure 19. North America Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Oligonucleotide Synthesis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
オリゴヌクレオチドプールの世界市場（～2026年） Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with a…- cDNA合成の世界市場（～2026年） Complementary DNA (cDNA) Synthesis has various application in bioinformatics as well as in genetics. cDNA is double-stranded DNA synthesized from a single stranded RNA. cDNA is mostly used for cloning eukaryotic genes in prokaryotes. It is used for transferring the cDNA which is used to code the pro…
- アンモニア合成触媒の世界市場（～2026年） Ammonia Synthesis Catalyst is used in the ammonia converters to convert synthesis gas containing hydrogen and nitrogen into ammonia. Market Analysis and Insights: Global Ammonia Synthesis Catalyst Market The global Ammonia Synthesis Catalyst market size is projected to reach US$ XX million by 2026, …
- 合成ガスの世界市場（～2026年） Syngas, or synthesis gas, is a fuel gas mixture consisting primarily of hydrogen, carbon monoxide, and very often some carbon dioxide. This market is driven by a number of factors, such as flexibility in feedstock, growing demand for electricity, and stringent environmental regulations. However, thi…
- トランスフェクション試薬・機器の世界市場（～2026年） The demand of transfection reagents and equipment will be increase in the future, because of the development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China. Market Analysis and Insights: Global Transfection Reagents and Equipment Mark…